Treatment of scalp psoriasis with phototherapy (UV-B-Comb) versus betamethasone valerate solution;UV-B-Kam versus betametasonopplosning ved hodebunnspsoriasis

Tidsskrift for den Norske Laegeforening

Volumn 120, Issue 16, 2000, Pages 1858-1859

  Dotterud, Lars Kåre ^a,b   Braun, Rosemarie ^a  

^a Hudavdelingen   (Norway)

^b Hudlegekontoret   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE VALERATE; ANTIINFLAMMATORY AGENT; BETAMETHASONE; GLUCOCORTICOID; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DRUG EFFECT; HUMAN; PHOTOTHERAPY; PSORIASIS; SKIN DISEASE; TREATMENT OUTCOME; ULTRAVIOLET B RADIATION; COMPARATIVE STUDY; EVALUATION; FEMALE; INSTRUMENTATION; MALE; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADULT; ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BETAMETHASONE; EVALUATION STUDIES; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; PSORIASIS; SCALP DERMATOSES; TREATMENT OUTCOME; ULTRAVIOLET THERAPY;

EID: 0034691109     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Lomholt G. Psoriasis. Prevalence, spontaneous course and genetics. Doktoravhandling, København: København Universitet, 1963.
2. Falk ES, Vanbakk Ø. Prevalence of psoriasis in a Norwegian Lapp population. Acta Derm Venereol (Stockh) 1993; 182: 6-9.
3. Farber EM, Jacobs PH, Nall ML. Relationship of mild to severe psoriasis. Cutis 1974; 13: 774-7.
4. Van de Kerkhof PCM, De Hoop D, De Korte J, Kuipers MV. Scalp psoriasis clinical presentations and therapeutic management. Dermatology 1998; 197: 326-34.
5. Fortune DG, Main CJ, Sullivan TMO, Griffiths CEM. Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress. Br J Dermatol 1997; 137: 755-60.
6. Farber EM, Nall L. Natural history and treatment of scalp psoriasis. Cutis 1992; 49: 396-400.
7. Austad J. Behandling av psoriasis i allmennpraksis. Tidsskr Nor Lægeforen 1997; 117: 2982-4.
8. Klaber MR, Hutchinson PE, Pedvis-Leftick A, Kragballe K, Reunala TL, Van de Kerkhof PCM et al. Comparative effects of calcipotriol solution (50 μg/ml) and betamethasone 17-valerate solution (1mg/ml) in the treatment of scalp psoriasis. Br J Dermatol 1994; 131: 678-83.
9. Lindelof B, Johannesson A. Psoriasis of the scalp treated with Grenz-rays with or without topical corticosteroid. Br J Dermatol 1988; 119: 241-4.
10. Caccialanza M, Piccinno R, Cappio F, Rozza M, Mainardi L. Phototherapy of psoriasis of the scalp. Results in 21 patients treated with a special portable ultraviolet rays lamp. G Ital Dermatol Venereol 1989; 124: 61-5.
11. Fredriksson T, Pettersson U. Severe psoriasis - oral therapy with a new retinoid. Dermatologica 1978; 157: 238-44.
12. Krutmann J. Wirkmechanismen der photo-und photochemotherapie. I: Krutmann J, Hönigsmann H. Handbuch der dermatologischen phototherapie und Photodiagnostik. Berlin: Springer-Verlag, 1997: 69-82.
13. Spuls PI, Witkamp L, Bossuyt PMM, Bos JD. A systematic review of five systemic treatments for severe psoriasis. Br J Dermatol 1997; 137: 943-9.
14. Lewis HM. Therapeutic progress II: treatment of psoriasis. J Clin Pharmacy Ther 1994; 19: 223-32.
15. Young A. Carcinogenicity of UV-B phototherapy assessed. Lancet 1995; 345: 1431-2.
16. Katz HI, Lindholm JS, Weiss JS, Shavin JS, Morman M, Bressinck R et al. Efficacy and safety of twice-daily augmented betamethasone dipropionate lotion versus clobetasol propionate solution in patients with moderate to severe scalp psoriasis. Clin Ther 1995; 17: 390-401.
17. Braun R, Dotterud LK, Falk ES. Comparison of betamethasone Valerate solution with phototherapy (UV-B comb) in scalp psoriasis treatment. Acta Derm Venereol (Stockh) 1998; 78: 385.